Alaunos Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of TCRT for the last quarter is 4.00 k USD, and it's 300.00% higher compared to the previous quarter. The net income of Q2 24 is -1.13 M USD.